Krebs Biochemicals & Industries Ltd
About
[
edit
]
Krebs Biochemicals & Industries is engaged in the business of manufacture of active pharmaceutical ingredients.
[
add key points
]
- Market Cap ₹ 214 Cr.
- Current Price ₹ 110
- High / Low ₹ 149 / 60.1
- Stock P/E
- Book Value ₹ -14.1
- Dividend Yield 0.00 %
- ROCE -57.0 %
- ROE %
- Face Value ₹ 10.0
Pros
- Company is expected to give good quarter
Cons
- Company has low interest coverage ratio.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
10.21 | 8.95 | 15.76 | 11.34 | 11.72 | 4.66 | 6.45 | 7.55 | 14.76 | 11.57 | 16.69 | 9.58 | |
15.17 | 11.75 | 16.31 | 15.39 | 14.12 | 9.67 | 11.59 | 12.00 | 18.79 | 15.87 | 19.79 | 15.23 | |
Operating Profit | -4.96 | -2.80 | -0.55 | -4.05 | -2.40 | -5.01 | -5.14 | -4.45 | -4.03 | -4.30 | -3.10 | -5.65 |
OPM % | -48.58% | -31.28% | -3.49% | -35.71% | -20.48% | -107.51% | -79.69% | -58.94% | -27.30% | -37.17% | -18.57% | -58.98% |
Other Income | 0.00 | 0.03 | 0.01 | 0.12 | 0.27 | 0.18 | 0.07 | 0.02 | 0.10 | 0.05 | 0.07 | 0.06 |
Interest | 1.42 | 1.42 | 1.46 | 1.46 | 1.90 | 1.61 | 1.63 | 1.70 | 0.99 | 1.23 | 2.12 | 1.43 |
Depreciation | 1.09 | 1.07 | 1.07 | 1.07 | 1.18 | 1.15 | 1.15 | 1.15 | 1.23 | 1.24 | 1.24 | 1.24 |
Profit before tax | -7.47 | -5.26 | -3.07 | -6.46 | -5.21 | -7.59 | -7.85 | -7.28 | -6.15 | -6.72 | -6.39 | -8.26 |
Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Net Profit | -7.47 | -5.27 | -3.07 | -6.46 | -5.21 | -7.59 | -7.85 | -7.28 | -6.16 | -6.72 | -6.39 | -8.26 |
EPS in Rs | -4.50 | -3.17 | -1.85 | -3.89 | -3.13 | -4.56 | -4.72 | -4.38 | -3.42 | -3.42 | -3.26 | -4.21 |
Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes |
Profit & Loss
Figures in Rs. Crores
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Jun 2013 | Sep 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
50 | 44 | 71 | 69 | 11 | 0 | 0 | 1 | 3 | 34 | 48 | 33 | 53 | |
78 | 40 | 70 | 73 | 24 | 4 | 38 | 15 | 12 | 41 | 58 | 52 | 70 | |
Operating Profit | -28 | 4 | 0 | -4 | -13 | -4 | -38 | -14 | -8 | -8 | -10 | -19 | -17 |
OPM % | -56% | 10% | 0% | -5% | -117% | -1,200% | -258% | -23% | -20% | -56% | -32% | ||
Other Income | 0 | -2 | 7 | 3 | 6 | 0 | 36 | 3 | -0 | -1 | 0 | 0 | 0 |
Interest | 6 | 7 | 8 | 9 | 1 | 0 | 4 | 1 | 3 | 5 | 6 | 6 | 6 |
Depreciation | 10 | 10 | 10 | 10 | 8 | 0 | 2 | 4 | 4 | 4 | 4 | 5 | 5 |
Profit before tax | -44 | -15 | -10 | -19 | -16 | -4 | -8 | -16 | -16 | -18 | -20 | -29 | -28 |
Tax % | 2% | 61% | 32% | 10% | 5% | -10% | 0% | 0% | 0% | 0% | 0% | 0% | |
Net Profit | -43 | -6 | -7 | -17 | -15 | -4 | -8 | -16 | -16 | -18 | -20 | -29 | -28 |
EPS in Rs | -38.75 | -5.15 | -6.07 | -15.17 | -13.22 | -3.78 | -6.82 | -10.33 | -9.67 | -10.73 | -12.03 | -16.04 | -14.31 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | -3% |
5 Years: | % |
3 Years: | 118% |
TTM: | 73% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -46% |
TTM: | 2% |
Stock Price CAGR | |
---|---|
10 Years: | 13% |
5 Years: | -0% |
3 Years: | -13% |
1 Year: | 16% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Balance Sheet
Figures in Rs. Crores
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Jun 2013 | Sep 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9 | 9 | 9 | 10 | 10 | 10 | 10 | 13 | 14 | 14 | 17 | 48 | 20 | |
Reserves | 43 | 37 | 30 | 14 | -2 | -6 | -14 | -4 | -12 | -32 | -31 | -43 | -47 |
Borrowings | 83 | 87 | 86 | 86 | 93 | 93 | 61 | 31 | 48 | 56 | 53 | 36 | 82 |
37 | 25 | 31 | 39 | 37 | 41 | 52 | 77 | 73 | 87 | 103 | 123 | 97 | |
Total Liabilities | 172 | 158 | 157 | 149 | 138 | 138 | 108 | 116 | 122 | 126 | 142 | 134 | 151 |
87 | 69 | 71 | 65 | 51 | 58 | 58 | 93 | 102 | 101 | 101 | 105 | 105 | |
CWIP | 4 | 4 | 0 | 0 | 7 | 0 | 0 | 11 | 4 | 4 | 3 | 4 | 14 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
81 | 85 | 86 | 83 | 80 | 80 | 50 | 13 | 16 | 21 | 38 | 24 | 32 | |
Total Assets | 172 | 158 | 157 | 149 | 138 | 138 | 108 | 116 | 122 | 126 | 142 | 134 | 151 |
Cash Flows
Figures in Rs. Crores
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Jun 2013 | Sep 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-4 | -16 | -5 | 7 | -2 | 49 | -45 | -15 | -11 | -6 | 4 | -36 | |
-4 | 12 | 4 | -1 | 6 | 0 | -3 | -4 | -5 | -3 | -4 | -9 | |
7 | 4 | 1 | -6 | -4 | -49 | 54 | 13 | 16 | 9 | 17 | 28 | |
Net Cash Flow | -0 | 0 | -0 | 0 | -0 | 0 | 6 | -6 | -0 | 0 | 17 | -17 |
Ratios
Figures in Rs. Crores
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Jun 2013 | Sep 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ROCE % | -25% | -4% | -2% | -9% | -15% | -4% | -9% | -33% | -27% | -26% | -36% | -57% |
Debtor Days | 216 | 233 | 69 | 41 | 30 | 10 | 180 | 3 | 22 | 2 | ||
Inventory Turnover | 0.89 | 1.11 | 1.84 | 1.93 | 0.36 | 0.06 | 0.02 | 0.54 | 0.29 | 2.48 | 3.36 | 2.18 |
Documents
Add documentRecent announcements
- Newspaper Advertisement - Intimation And Outcome Of Board Meeting 2 Feb
- Outcome Of Board Meeting Dated 30Th January, 2021 30 Jan
- Financial Results For The Quarter Ended 31St December, 2020 30 Jan
- Board Meeting Intimation for Notice Of Board Meeting To Be Held On 30Th January, 2021 23 Jan
- Shareholding for the Period Ended December 31, 2020 9 Jan
View all